ZEB1 and gastric cancer: Paclitaxel (PTX) is an effective first-line chemotherapy drug in GC treatment, and circPVT1 contributes to PTX resistance and GC cell invasion via serving as a ceRNA against miR-124-3p to target ZEB1, a crucial transcriptional inhibitor of E-cadherin [104].